BCG Apogepha 50 mg

BCG Apogepha 50 mg is a medicine authorised by Swissmedic under authorisation number 68286. The authorisation holder is Regulix GmbH. The medicinal product code is Bacterial and yeast preparations and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 July 2022 and the authorisation is limited until 27 July 2027. The export lists no ATC code for this medicine.

  • Dispensing category A
  • Authorisation number 68286
  • Bacterial and yeast preparations
Authorisation data
Authorisation number68286
NameBCG Apogepha 50 mg
Full nameBCG Apogepha 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen Anwendung
Authorisation holderRegulix GmbH
Medicinal product codeBacterial and yeast preparations
Dispensing categoryA · Prescription, not repeatable
ATC codenot stated
First authorisation28 July 2022
Authorisation validity27 July 2027
Strengths
No.NameDispensing categoryAuthorisation date
1BCG Apogepha 50 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungA28 July 2022
2BCG Apogepha 100 mg, Pulver und Lösungsmittel zur Herstellung einer Suspension zur intravesikalen AnwendungA28 July 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is BCG Apogepha 50 mg authorised in Switzerland?

Yes. BCG Apogepha 50 mg is authorised by Swissmedic under authorisation number 68286, data as of 01 September 2026. The authorisation is limited until 27 July 2027.

Which dispensing category does BCG Apogepha 50 mg have?

BCG Apogepha 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of BCG Apogepha 50 mg?

The authorisation holder is Regulix GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com